Impact of isotype on the mechanism of action of agonist anti-OX40 antibodies in cancer: implications for therapeutic combinations

Jane E Willoughby, Lang Dou, Sabyasachi Bhattacharya, Heather Jackson, Laura Seestaller-Wehr, David Kilian, Laura Bover, Kui S Voo, Kerry L Cox, Tom Murray, Mel John, Hong Shi, Paul Bojczuk, Junping Jing, Heather Niederer, Andrew J Shepherd, Laura Hook, Stephanie Hopley, Tatyana Inzhelevskaya, Chris A Penfold, C Ian Mockridge, Vikki English, Sara J Brett, Roopa Srinivasan, Christopher Hopson, James Smothers, Axel Hoos, Elaine Paul, Stephen L Martin, Peter J Morley, Niranjan Yanamandra, Mark S Cragg

Open source

DOI: 10.1136/jitc-2023-008677
Published: 2024-07
Container: Journal for ImmunoTherapy of Cancer
Publisher: BMJ
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/jitc-2023-008677,
  title = {Impact of isotype on the mechanism of action of agonist anti-OX40 antibodies in cancer: implications for therapeutic combinations},
  author = {Jane E Willoughby and Lang Dou and Sabyasachi Bhattacharya and Heather Jackson and Laura Seestaller-Wehr and David Kilian and Laura Bover and Kui S Voo and Kerry L Cox and Tom Murray and Mel John and Hong Shi and Paul Bojczuk and Junping Jing and Heather Niederer and Andrew J Shepherd and Laura Hook and Stephanie Hopley and Tatyana Inzhelevskaya and Chris A Penfold and C Ian Mockridge and Vikki English and Sara J Brett and Roopa Srinivasan and Christopher Hopson and James Smothers and Axel Hoos and Elaine Paul and Stephen L Martin and Peter J Morley and Niranjan Yanamandra and Mark S Cragg},
  year = {2024},
  journal = {Journal for ImmunoTherapy of Cancer},
  doi = {10.1136/jitc-2023-008677},
  url = {https://doi.org/10.1136/jitc-2023-008677}
}

RIS

TY  - JOUR
TI  - Impact of isotype on the mechanism of action of agonist anti-OX40 antibodies in cancer: implications for therapeutic combinations
AU  - Jane E Willoughby
AU  - Lang Dou
AU  - Sabyasachi Bhattacharya
AU  - Heather Jackson
AU  - Laura Seestaller-Wehr
AU  - David Kilian
AU  - Laura Bover
AU  - Kui S Voo
AU  - Kerry L Cox
AU  - Tom Murray
AU  - Mel John
AU  - Hong Shi
AU  - Paul Bojczuk
AU  - Junping Jing
AU  - Heather Niederer
AU  - Andrew J Shepherd
AU  - Laura Hook
AU  - Stephanie Hopley
AU  - Tatyana Inzhelevskaya
AU  - Chris A Penfold
AU  - C Ian Mockridge
AU  - Vikki English
AU  - Sara J Brett
AU  - Roopa Srinivasan
AU  - Christopher Hopson
AU  - James Smothers
AU  - Axel Hoos
AU  - Elaine Paul
AU  - Stephen L Martin
AU  - Peter J Morley
AU  - Niranjan Yanamandra
AU  - Mark S Cragg
PY  - 2024
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2023-008677
UR  - https://doi.org/10.1136/jitc-2023-008677
ER  -

APA

Willoughby, J. E., Dou, L., Bhattacharya, S., Jackson, H., Seestaller-Wehr, L., Kilian, D., Bover, L., Voo, K. S., Cox, K. L., Murray, T., John, M., Shi, H., Bojczuk, P., Jing, J., Niederer, H., Shepherd, A. J., Hook, L., Hopley, S., Inzhelevskaya, T., Penfold, C. A., Mockridge, C. I., English, V., Brett, S. J., Srinivasan, R., Hopson, C., Smothers, J., Hoos, A., Paul, E., Martin, S. L., Morley, P. J., Yanamandra, N., & Cragg, M. S. (2024). Impact of isotype on the mechanism of action of agonist anti-OX40 antibodies in cancer: implications for therapeutic combinations. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2023-008677

Source records

crossref · retrieved 2026-09-27T05:32:39.913Z